A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
Conditions: Eosinophilic Gastritis; Eosinophilic Duodenitis Interventions: Drug: antolimab (AK002); Other: Placebo Sponsor: Allakos, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials